Stockreport

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance [Read more]